TNK-tPA, rt-PA, Acute stroke, phase Ⅲ trial
Showing 1 - 25 of >10,000
Acute Ischemic Stroke Trial in China (Alteplase, Tenecteplase)
Recruiting
- Acute Ischemic Stroke
-
Xuancheng, Anhui, China
- +62 more
Feb 16, 2023
Stroke Trial in ShenYang (rt-PA, Argatroban)
Completed
- Stroke
-
ShenYang, ChinaGeneral Hospital of ShenYang Military Region
Feb 20, 2022
Acute Ischemic Stroke Trial in China (Alteplase, Tenecteplase)
Active, not recruiting
- Acute Ischemic Stroke
-
Beijing, Beijing, China
- +27 more
Mar 16, 2022
Ischemic Stroke, Acute Trial in Beijing (rhTNK-tPA ( 0.25 mg/kg, Max 25 mg ), standard medical treatment)
Recruiting
- Ischemic Stroke, Acute
- rhTNK-tPA ( 0.25 mg/kg, Max 25 mg )
- standard medical treatment
-
Beijing, Beijing, ChinaBeijing Tiantan Hospital, Capital Medical University
Jan 29, 2022
Ischemic Stroke Trial in Calgary (Tenecteplase)
Completed
- Ischemic Stroke
-
Calgary, Alberta, CanadaUniversity of Calgary
Nov 23, 2020
Acute Ischemic Stroke Trial in Barcelona (Tenecteplase)
Recruiting
- Acute Ischemic Stroke
-
Barcelona, SpainHospital Universitari Vall d'Hebron
Nov 22, 2022
Stroke Trial in Shenyang (Tenecteplase)
Completed
- Stroke
-
Shenyang, ChinaDepartment of Neurology, General Hospital of Northern Theater Co
Jul 31, 2022
INtravenous TNK for Acute isChemicsTroke in China
Recruiting
- Stroke, Ischemic
-
Shenyang, ChinaDepartment of Neurology, General Hospital of Northern Theater Co
Jan 30, 2023
Ischemic Stroke, Acute Trial (Recombinant Human tenecteplase Tissue-type Plasminogen Activator (rhTNK-tPA), Best Medical
Not yet recruiting
- Ischemic Stroke, Acute
- Recombinant Human tenecteplase Tissue-type Plasminogen Activator (rhTNK-tPA)
- Best Medical Management
- (no location specified)
Nov 24, 2022
Acute Ischemic Stroke Trial in China (Injection of recombinant human tissue plasminogen kinase derivatives, Recombinant human
Recruiting
- Acute Ischemic Stroke
- Injection of recombinant human tissue plasminogen kinase derivatives
- Recombinant human tissue plasminogen activator
-
Bengbu, Anhui, China
- +77 more
Oct 14, 2022
Stroke, Acute Ischemic, Stroke, Acute Trial in Spain (Intraarterial alteplase)
Not yet recruiting
- Stroke, Acute Ischemic
- Stroke, Acute
- Intraarterial alteplase
-
Badalona, Spain
- +11 more
Mar 21, 2023
Stroke, Acute Trial in Worldwide (Tenecteplase, Antiplatelet treatment)
Recruiting
- Stroke, Acute
- Tenecteplase
- Antiplatelet treatment
-
Canberra, Australian Capital Territory, Australia
- +60 more
May 16, 2022
Acute Ischemic Stroke Trial (rhTNK-tPA, Antiplatelet Agents)
Not yet recruiting
- Acute Ischemic Stroke
- rhTNK-tPA
- Antiplatelet Agents
- (no location specified)
Mar 1, 2023
Stroke, Acute, Stroke, Ischemic Trial in China (rhTNK-tPA, Endovascular treatment)
Recruiting
- Stroke, Acute
- Stroke, Ischemic
- rhTNK-tPA
- Endovascular treatment
-
Chongqing, Chongqing, China
- +4 more
Oct 15, 2022
Acute Ischemic Stroke Trial in Columbia (Thrombectomy)
Completed
- Acute Ischemic Stroke
- Thrombectomy
-
Columbia, MissouriUniversity of Missouri
Dec 18, 2021
Stroke, Ischemic Trial in Taipei (Endovascular thrombectomy)
Recruiting
- Stroke, Ischemic
- Endovascular thrombectomy
-
Taipei, TaiwanNational Taiwan University Hospital
Mar 6, 2022
Acute Ischemic Stroke Trial in Tianjin (Intra-Arterial TNK and Albumin, Intra-Arterial TNK, Intra-Arterial Albumin)
Recruiting
- Acute Ischemic Stroke
- Intra-Arterial TNK and Albumin
- +3 more
-
Tianjin, Tianjin, ChinaTianjin Huanhu Hospital
Oct 27, 2023
Acute Ischaemic Stroke Trial in China (Recombinant human urokinase, Alteplase)
Completed
- Acute Ischaemic Stroke
- Recombinant human urokinase
- Alteplase
-
Beijing, Beijing, China
- +34 more
Jun 18, 2020
Basilar Artery Occlusion, Acute Cerebrovascular Accident, Stroke Due to Basilar Artery Occlusion Trial (Tenecteplase, Aspiration
Not yet recruiting
- Basilar Artery Occlusion
- +2 more
- Tenecteplase
- +2 more
- (no location specified)
Jan 18, 2023